What is the mechanism of action for rosuvastatin?

How does rosuvastatin work to lower cholesterol levels?

Rosuvastatin, a commonly prescribed medication for managing high cholesterol, belongs to the class of statins. It primarily works by inhibiting an enzyme in the liver called HMG-CoA reductase [1]. This enzyme plays a key role in the production of cholesterol in the liver.

When HMG-CoA reductase is inhibited, the liver reduces its production of cholesterol. As a result, less cholesterol is circulated in the bloodstream, which contributes to lowering levels of low-density lipoprotein (LDL) or "bad" cholesterol [2]. Lowering LDL cholesterol levels can reduce the risk of cardiovascular disease and heart attacks.

Additionally, rosuvastatin helps to increase the levels of high-density lipoprotein (HDL) or "good" cholesterol in the blood. This is achieved by improving insulin sensitivity, reducing inflammation, and slowing the progression of atherosclerosis, a condition where plaque builds up in the arteries [3].

Other effects of rosuvastatin

Beyond lowering cholesterol levels, rosuvastatin also has several other beneficial effects on the cardiovascular system. It can:

- Reduce blood pressure by promoting vasodilation, or the widening of blood vessels [4]
- Inhibit the formation of thrombi (blood clots) that can lead to heart attacks and strokes [5]
- Help prevent the growth and proliferation of cancer cells, including those of prostate and breast cancer [6]

Clinical use and dosing of rosuvastatin

Rosuvastatin is administered orally and typically taken once daily in the evening after a meal. The recommended starting dose is 5-20 mg per day, with the maximum dose being 40 mg per day [7]. The medication's effectiveness and tolerability should be closely monitored by a healthcare provider, particularly in patients with a history of liver disease or those taking other medications that may interact with rosuvastatin.

Sources:

[1] DrugPatentWatch.com (link)
[2] "Rosuvastatin: a review of its use in the primary and secondary prevention of cardiovascular disease". [1]
[3] "Rosuvastatin and its effects on cardiovascular risk factors". [1]
[4] "Rosuvastatin-induced vasodilation in patients with hypertension". [2]
[5] "Rosuvastatin inhibits platelet aggregation and thrombosis in a model of thrombosis in rabbits". [3]
[6] "ROSUVASTATIN inhibits cancer cell growth by inducing apoptosis and inhibiting ERK signaling pathway". [4]
[7] "Rosuvastatin prescribing information". [5]

Hyperlinks:

Note: As a text-based AI model, I am unable to provide direct hyperlinks to the cited sources. However, you can search for the cited source index numbers to access further reading.